Auto-disable Syringes Market - Introduction
Safety syringes are Safety Engineered Device (SED) that use injury protection mechanism which provides protection from blood borne pathogens or chemical hazards. Infection prevention among patients as well as health care professionals such as doctors, nurses, and other staff is one of the major goals in hospitals, ambulatory surgical centers, and other health institutes. Needlestick injuries could lead to transmission of blood borne pathogens such as human immunodeficiency virus (HIV), hepatitis B, and hepatitis C. Auto-disable syringe is a type of safety syringe used for various purposes in health care. Auto-disable syringe is an effective means for eliminating needle stick injury and preventing reuse.
Auto-disable Syringes Market – Competitive Landscape
Key players operating in the global auto-disable syringes market are Becton Dickinson & Company (BD), JMI Group, AdvaCare Pharma, AlShifa Medical Syringe Manufacturing Company, Vogt Medical, Retractable Technologies, Inc., ZIBO EASTMED HEALTHCARE PRODUCTS CO., LTD., Hindustan Syringes and Medical Devices, L.O.M. Medical International, and SRS Meditech Limited, among others.
Becton Dickinson & Company
Becton Dickinson & Company (BD) is a medical device company manufacturing wide range of laboratory equipment, medical supplies, devices, and diagnostic products. The company mainly offers products to clinical laboratories, healthcare institutions, life science researchers and others. BD SoloShot Syringe BCG auto-disable syringe is a major product offered by the company in the market.
Identify the key factors that will drive your company’s growth, Request a brochure of this report here
Vogt Medical is a medical device manufacturers offering products such as injection systems, infusion and transfusion therapy systems, blood collection systems, regional anesthesia systems, urology products and others. Vogt Medical auto disable syringes are automatically blocked following injection and are made up of medical grade materials.
AdvaCare Pharma is a pharmaceutical and medical device company with 400 branded pharmaceutical & veterinary products and five medical device divisions. The AccuPoint brand of auto-disable syringes manufactured by the company encompasses broad range of capacities and closure types. The auto-disable syringe product line offered by the company is ISO, CE and US Food and Drug Administration (FDA) approved.
Auto-disable Syringes Market – Dynamics
The global auto-disable syringes market is driven by technological advancements, increase in demand for safety syringes, rise in adoption of preventive care strategies in health care organizations, and increase in awareness about the disadvantages of unsafe syringes and a need to use safety syringes.
Increase in demand for safety syringes
Healthcare professional have become awareness about safe healthcare delivery and prevention of infections and communicable diseases. They are also aware about consequences of using unsafe syringes. According to the WHO, every year, usage of unsafe syringes in health care centers accounts for nearly 1.3 million deaths across the globe. According to Centre for Diseases Control and Prevention (CDC), nearly 385,000 sharps injuries occur annually to health care workers in the U.S. alone.
Organization efforts towards safe healthcare practices
A number of regulatory and non-government organizations are encouraging the use of auto-disable syringes. The National Institute for Occupational Safety and Health (NIOSH) launched the STOP STICKS Campaign to create awareness about needlestick and sharps-related injuries. Organizations such as the World Health Organization (WHO) have formulated various policies and guidelines for the use of sharps in health care settings. Additionally, the WHO established “Safe Injection Global Network” (SIGN) which aims to increase the use of safety syringes and avoid the risk of infection in hospitals. Also, U.S. government passed the bill and signed into law the Needlestick Safety and Prevention Act 2000. This law requires employers to identify, and implement safer medical devices. The law was signed in November, 2000.
Expanding operations in future? To get the perfect launch ask for a custom report here
North America to continue its dominance in the market
North America is anticipated to dominate the market owing to technological developments, new product launches, and rapid adoption of blood collection & blood drawing technologies. Additionally, increase in the use of retractable syringes as one of the key safety measures and availability of these syringes with improved functionality are anticipated to boost the growth of the market in the region. Furthermore, market growth in the U.S. is fuelled by regulatory approvals, increase in the number of market players offering safety syringes, and rise in focus on safe injection practices in hospitals and surgical centers.
Significant growth opportunities in Asia Pacific
The auto-disable syringes market in Asia Pacific is driven by product launch in emerging economies and increase in demand for safe administration of therapeutics in hospitals & clinics. In November 2018, Andhra Pradesh (India) announced it will use auto-disable syringes for all clinical purposes to reduce infections in health care settings. According to the Neuro-Developmental Disorders in India, nearly 4 billion syringes are used in India each year; of these nearly 60% are unsafe. This fuels the demand for safety syringes. In order to tackle this problem, a number of hospitals are switching to smart syringes such as auto-disable syringes.
Auto-disable Syringes Market – Segmentation
The auto-disable syringes Market can be bifurcated on the basis of application, and end-user
In terms of application, the Auto-disable Syringes Market can be divided into:
- Blood Collection
- Drug Delivery
In terms of end-user, the auto-disable syringes market can be fragmented into:
- Ambulatory Surgical Centers
- Diagnostic Laboratories
This study by TMR is all-encompassing framework of the dynamics of the market. It mainly comprises critical assessment of consumers' or customers' journeys, current and emerging avenues, and strategic framework to enable CXOs take effective decisions.
Our key underpinning is the 4-Quadrant Framework EIRS that offers detailed visualization of four elements:
- Customer Experience Maps
- Insights and Tools based on data-driven research
- Actionable Results to meet all the business priorities
- Strategic Frameworks to boost the growth journey
The study strives to evaluate the current and future growth prospects, untapped avenues, factors shaping their revenue potential, and demand and consumption patterns in the global market by breaking it into region-wise assessment.
The following regional segments are covered comprehensively:
- North America
- Asia Pacific
- Latin America
- The Middle East and Africa
The EIRS quadrant framework in the report sums up our wide spectrum of data-driven research and advisory for CXOs to help them make better decisions for their businesses and stay as leaders.
Below is a snapshot of these quadrants.
1. Customer Experience Map
The study offers an in-depth assessment of various customers’ journeys pertinent to the market and its segments. It offers various customer impressions about the products and service use. The analysis takes a closer look at their pain points and fears across various customer touchpoints. The consultation and business intelligence solutions will help interested stakeholders, including CXOs, define customer experience maps tailored to their needs. This will help them aim at boosting customer engagement with their brands.
2. Insights and Tools
The various insights in the study are based on elaborate cycles of primary and secondary research the analysts engage with during the course of research. The analysts and expert advisors at TMR adopt industry-wide, quantitative customer insights tools and market projection methodologies to arrive at results, which makes them reliable. The study not just offers estimations and projections, but also an uncluttered evaluation of these figures on the market dynamics. These insights merge data-driven research framework with qualitative consultations for business owners, CXOs, policy makers, and investors. The insights will also help their customers overcome their fears.
3. Actionable Results
The findings presented in this study by TMR are an indispensable guide for meeting all business priorities, including mission-critical ones. The results when implemented have shown tangible benefits to business stakeholders and industry entities to boost their performance. The results are tailored to fit the individual strategic framework. The study also illustrates some of the recent case studies on solving various problems by companies they faced in their consolidation journey.
4. Strategic Frameworks
The study equips businesses and anyone interested in the market to frame broad strategic frameworks. This has become more important than ever, given the current uncertainty due to COVID-19. The study deliberates on consultations to overcome various such past disruptions and foresees new ones to boost the preparedness. The frameworks help businesses plan their strategic alignments for recovery from such disruptive trends. Further, analysts at TMR helps you break down the complex scenario and bring resiliency in uncertain times.
The report sheds light on various aspects and answers pertinent questions on the market. Some of the important ones are:
1. What can be the best investment choices for venturing into new product and service lines?
2. What value propositions should businesses aim at while making new research and development funding?
3. Which regulations will be most helpful for stakeholders to boost their supply chain network?
4. Which regions might see the demand maturing in certain segments in near future?
5. What are the some of the best cost optimization strategies with vendors that some well-entrenched players have gained success with?
6. Which are the key perspectives that the C-suite are leveraging to move businesses to new growth trajectory?
7. Which government regulations might challenge the status of key regional markets?
8. How will the emerging political and economic scenario affect opportunities in key growth areas?
9. What are some of the value-grab opportunities in various segments?
10. What will be the barrier to entry for new players in the market?
Note: Although care has been taken to maintain the highest levels of accuracy in TMR’s reports, recent market/vendor-specific changes may take time to reflect in the analysis.